Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,841,370
+$4,631,735 QoQ
Shares Held
29,882
-11.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#640
of 4,587 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $668,956,159 across 9 Drug Manufacturers - General names. LLY ranks #3 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
851,550 | $308,363,285 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,158,772 | $272,739,254 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
29,882 | $35,841,370 | |
| 4 | JNJ |
Johnson & Johnson
|
103,280 | $26,230,021 | |
| 5 | MRK |
Merck & Co., Inc.
|
113,061 | $14,528,338 | |
| 6 | ABBV |
AbbVie Inc.
|
40,476 | $10,185,380 | |
| 7 | PFE |
Pfizer Inc
|
38,431 | $925,418 | |
| 8 | BIIB |
Biogen Inc.
|
338 | $73,028 |
All Filings in LLY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,841,370 | 29,882 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,209,635 | 33,932 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $36,542,347 | 34,003 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $30,912,182 | 40,514 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $31,898,367 | 40,920 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $36,048,493 | 43,647 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $35,098,980 | 45,465 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $39,199,301 | 44,246 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $44,973,846 | 49,674 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $45,094,451 | 57,965 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $32,767,099 | 56,212 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $43,798,117 | 81,541 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $44,625,791 | 95,155 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,696,572 | 10,764 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,044,361 | 11,055 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,068,591 | 9,490 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $314,178 | 969 | Shares | Defined | 2022-08-11 | |
| 2021-12-31 | $2,086,013 | 7,552 | Shares | Defined | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||